February 19, 2019

FDA: Class I recall of Medtronic’s Dual Chamber Implantable Pulse Generators

By: Judy Mathias

Editor's Note

The Food & Drug Administration (FDA) on February 15 identified Medtronic, Inc’s (Dublin, Ireland) recall of it’s Dual Chamber Implantable Pulse Generators (IPGs) as Class I, the most serious.

The recall was initiated because of the possibility of a software error that can result in a lack of pacing. A lack of pacing could result in patients experiencing slow heart beating, low blood pressure, light headedness, fainting, and death.

Sponsored Message

Distribution dates for the IPGs were March 6, 2017 to January 7, 2019.


Sign Up For OR a.m.
Sign up for the free OR a.m. eLetter to get news like this in your inbox every morning!

OR Manager Jobs
Live chat by BoldChat